NCT00334503

Brief Summary

The purpose of this study is to evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus treated with Biguanide.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

13 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 5, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 7, 2006

Completed
Last Updated

October 10, 2008

Status Verified

October 1, 2008

First QC Date

June 5, 2006

Last Update Submit

October 8, 2008

Conditions

Type 2 Diabetes Mellitus

Keywords

alpa-glucosidase inhibitor,Biguanide

Interventions

MiglitolDRUG

Eligibility Criteria

Age20 Years - 69 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Type 2 diabetic patients with Biguanide treatment
  • Criteria for postprandial plasma glucose and HbA1c are met

You may not qualify if:

  • Type 1 diabetes
  • Patients treated with other antidiabetic drugs or Insulin

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (13)

Unknown Facility

Aichi, Japan

Location

Unknown Facility

Chiba, Japan

Location

Unknown Facility

Fukuoka, Japan

Location

Unknown Facility

Gunma, Japan

Location

Unknown Facility

Hokkaido, Japan

Location

Unknown Facility

Ibaraki, Japan

Location

Unknown Facility

Kagoshima, Japan

Location

Unknown Facility

Kanagawa, Japan

Location

Unknown Facility

Kumamoto, Japan

Location

Unknown Facility

Miyazaki, Japan

Location

Unknown Facility

Osaka, Japan

Location

Unknown Facility

Ōita, Japan

Location

Unknown Facility

Saitama, Japan

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

miglitol

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Clinical Study Group, Clinical Development Dept.

    Sanwa Kagaku Kenkyusho Co., Ltd.

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

June 5, 2006

First Posted

June 7, 2006

Last Updated

October 10, 2008

Record last verified: 2008-10

Locations

JP(13)